Delivery Order SPE2DB22D9130-SPE2DB25FE0GA
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $16,249.95 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Stelara 90 mg/ml syringes. The contract carries an ultimate completion date of October 2, 2025, and does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/ml syringes. The award, issued on August 20, 2025, with an ultimate completion date of September 11, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency valued at $16,249.95 for the supply of Stelara 90 mg/ml syringes. The award, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for STELARA 90 mg/mL syringes. This firm fixed-price delivery order, issued on June 6, 2025, with an ultimate completion date of June 30, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/ml syringes. The contract, awarded on September 15, 2025, carries a firm fixed-price structure with an ultimate completion date of October 6, 2025. This delivery order does not utilize a set-aside designation and represents a continuation of DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Stelara 90 mg/mL syringes. The award represents a firm fixed-price delivery order with no set-aside designation, utilizing the company's existing Indefinite Delivery Contract with DLA under the SPE2DB program. The product will be delivered to Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on July 24, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order carries an ultimate completion date of August 14, 2025, and does not utilize a set-aside designation. This award falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 on August 19, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order, which carries a firm fixed price and is not subject to any set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and must be completed by September 10, 2025. This award represents a single delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for Stelara 90 mg/mL syringes valued at $16,249.95 by the Defense Logistics Agency (DLA) on August 15, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of September 8, 2025, represents a standard procurement action with no set-aside designation. The contract will be performed at the awardee's facility in Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on June 5, 2025, for the supply of Stelara 90 mg/ml syringes. The contract carries no set-aside designation and is scheduled for completion by June 27, 2025, with performance to be executed at the vendor's Park Ridge, Illinois location. This delivery order is issued under DMS...
- SPE2DB22D9130Indefinite Delivery Contract
- SPE2DB22D9130-SPE2DB25FE0GADelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 16, 2025, by the Defense Logistics Agency (DLA) for Stelara 90 mg/mL syringes, valued at $16,249.95. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which is valued at $500 million and extends through November 2026. The delivery order carries no set-aside designation and has an ultimate completion date of October 7, 2025, with performance taking place at the contractor's Park Ridge, Illinois facility. Stelara is a biologic immunosuppressant medication commonly used in military and federal healthcare settings to treat conditions such as plaque psoriasis, psoriatic arthritis, and inflammatory bowel disease. This award reflects DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain, providing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's comprehensive IDC portfolio with the DLA enables efficient procurement of a wide range of pharmaceutical products to support medical supply needs across military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 9/16/25 |